INAB – in8bio, inc. (US:NASDAQ)
Stock Stats
News
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Form 8-K IN8BIO, INC. For: Nov 21
Form S-3 IN8BIO, INC.
Form 10-Q IN8BIO, INC. For: Sep 30
Form 8-K IN8BIO, INC. For: Nov 06
Form 8-K IN8BIO, INC. For: Oct 27
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.